Article
An aptamer targets HBV core protein and suppresses HBV replication in HepG2.2.15 cells
19 Aug 2014
Abstract excerpt
Hepatitis B virus (HBV)-related hepatitis is a major health concern worldwide. As current anti-HBV therapies are limited, it is essential to develop new strategies. Aptamer, a newly developed adaptive molecule (single-strand DNA or RNA also known as nucleotide antibody), is a new strategy for clinical diagnosis and therapy due to its high affinity and specificity. In the present study, by systematic evolution of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
